entity

APP processing

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about APP processing: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

14Connections
4Hypotheses
6Analyses
2Outgoing
12Incoming
0Experiments
7Debates

No AI portrait yet

Outgoing (2)

TargetRelationTypeStr
amyloid productioncausesprocess0.90
tau spread susceptibilitymodulatesmechanism0.50

Incoming (12)

SourceRelationTypeStr
HOPSregulatesprotein0.95
GGA Proteinsmodulatesprotein0.90
neuronal activityactivatesprocess0.90
Cargo Segregationregulatesprocess0.88
Lysosomeinvolved_incell_type0.85

Targeting Hypotheses (4)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Endosomal trafficking defects are the common upstream lesion 0.730 neurodegeneration What determines the temporal sequence of
Cdk5/p25-PSD-95 Phosphorylation Disrupts Synaptic Scaffoldin 0.455 neurodegeneration Quantitative proteomics of the aging syn
Synaptic Vesicle Protein Phosphorylation Reprograms Release 0.455 neurodegeneration Quantitative proteomics of the aging syn
APP Processing Compartmentalization Therapeutics 0.000 - Lipid raft composition changes in synapt

Mentioning Analyses (6)

Scientific analyses that reference this entity

What determines the temporal sequence of cholinergic dysfunction versus amyloid/

neurodegeneration | 2026-04-25 | 7 hypotheses Top: 0.730

Human connectome alterations in Alzheimer's disease: structural and functional n

connectomics | 2026-04-16 | 13 hypotheses Top: 0.535

Lipid metabolism dysregulation in Alzheimer's disease: membrane rafts, gangliosi

lipidomics | 2026-04-16 | 13 hypotheses Top: 0.802

What molecular mechanisms link elevated sphingomyelin synthase activity to incre

neurodegeneration | 2026-04-15 | 1 hypotheses Top: 0.734

What molecular mechanisms mediate HDAC9's effects on Aβ deposition and synaptic

neurodegeneration | 2026-04-14 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (7)

Multi-agent debates referencing this entity

Structured research brief (iter2): ω-3 Docosahexaenoic Acid (DHA) Epoxide Genera

archived · Rounds: 2 · Score: 0.64 · 2026-04-28

What determines the temporal sequence of cholinergic dysfunction versus amyloid/

closed · Rounds: 4 · Score: 0.65 · 2026-04-25

How does lipid metabolism dysregulation contribute to amyloidogenesis and tau pa

closed · Rounds: 4 · Score: 0.50 · 2026-04-18

How does the human brain connectome reorganize in Alzheimer's disease, and what

closed · Rounds: 4 · Score: 0.50 · 2026-04-18

The abstract shows HDAC9 overexpression reduces Aβ deposition and improves synap

closed · Rounds: 4 · Score: 0.95 · 2026-04-16

The study demonstrates that SGMS1 elevation correlates with increased Aβ and tha

closed · Rounds: 4 · Score: 0.75 · 2026-04-16

The abstract explicitly questions whether AD's hallmark pathologies induce choli

closed · Rounds: 4 · Score: 0.79 · 2026-04-12

Related Research

Hypotheses and analyses mentioning APP processing in their description or question text

No additional research found